Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose Positron Emission Tomography Is Associated With the Metabolic Syndrome
Nobuhiro Tahara, MD, PhD*,*,
Hisashi Kai, MD, PhD*,
Sho-ichi Yamagishi, MD, PhD*,
Minori Mizoguchi, MD*,
Hiroyuki Nakaura, MD, PhD*,
Masatoshi Ishibashi, MD, PhD ,
Hayato Kaida, MD, PhD,
Kenkichi Baba, MD,
Naofumi Hayabuchi, MD, PhD and
Tsutomu Imaizumi, MD, PhD*
* Department of Medicine, Division of Cardio-Vascular Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan.
View larger version (89K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Representative Coronal Images of FDG-PET in the Carotid Arteries of a Normal Subject and a Patient With the Metabolic Syndrome
Red arrows indicate vascular [18F]-fluorodeoxyglucose (FDG) uptake within the carotid arteries in a patient with the metabolic syndrome (right, A). Representative transaxial images of FDG positron emission tomography (PET), contrast enhanced computed tomography (CT), and the co-registration of PET and CT (PET/CT), showing FDG uptake within the carotid artery in the patient with metabolic syndrome (B). Black arrow-arrowhead denotes vessel wall or atherosclerotic plaque. Red arrow-arrowhead indicates FDG vascular uptake.
|
|
|
